{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-052249","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2024-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.207822+00:00","generated_at":"2026-05-28T22:59:40.229634+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lixte Biotechnology VP and COO Eric Forman resigns effective Dec 31, 2024","bullets":["Eric Forman resigned as VP and COO of Lixte Biotechnology Holdings, effective December 31, 2024.","Resignation is for personal reasons; no disagreement with company operations, policies, or practices.","Employment agreement dated July 15, 2020 (amended Aug 12, 2020 and Nov 6, 2022) terminates on Dec 31, 2024.","No replacement or interim appointment has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-052249","json":"https://secwatch.observer/filing/0001493152-24-052249.json","markdown":"https://secwatch.observer/filing/0001493152-24-052249.md","text":"https://secwatch.observer/filing/0001493152-24-052249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315224052249/0001493152-24-052249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315224052249/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T22:59:40.229634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}